Its valuation is considered undervalued, Institutional ownership is very low.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Universe Pharmaceuticals Inc's Score
Industry at a Glance
Industry Ranking
140 / 173
Overall Ranking
621 / 4682
Industry
Pharmaceuticals
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Universe Pharmaceuticals Inc Highlights
StrengthsRisks
Universe Pharmaceuticals Inc is a China-based holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The Company mainly conducts its businesses within the Chinese market.
Growing
The company is in a growing phase, with the latest annual income totaling USD 23.02M.
Overvalued
The company’s latest PE is 0.00, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 0.00 shares, decreasing 100.00% quarter-over-quarter.
Universe Pharmaceuticals Inc is a China-based holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The Company mainly conducts its businesses within the Chinese market.
Ticker SymbolUPC
CompanyUniverse Pharmaceuticals Inc
CEOLai (Gang)
Websitehttp://www.universe-pharmacy.com/
FAQs
What is the current price of Universe Pharmaceuticals Inc (UPC)?
The current price of Universe Pharmaceuticals Inc (UPC) is 4.290.
What is the symbol of Universe Pharmaceuticals Inc?
The ticker symbol of Universe Pharmaceuticals Inc is UPC.
What is the 52-week high of Universe Pharmaceuticals Inc?
The 52-week high of Universe Pharmaceuticals Inc is 28.000.
What is the 52-week low of Universe Pharmaceuticals Inc?
The 52-week low of Universe Pharmaceuticals Inc is 2.510.
What is the market capitalization of Universe Pharmaceuticals Inc?
The market capitalization of Universe Pharmaceuticals Inc is 2.42M.
What is the net income of Universe Pharmaceuticals Inc?
The net income of Universe Pharmaceuticals Inc is -8.73M.
Is Universe Pharmaceuticals Inc (UPC) currently rated as Buy, Hold, or Sell?
According to analysts, Universe Pharmaceuticals Inc (UPC) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of Universe Pharmaceuticals Inc (UPC)?
The Earnings Per Share (EPS TTM) of Universe Pharmaceuticals Inc (UPC) is 1519.635.